Continuous advances in molecular biology have resulted in the emergence of new scientific disciplines such as genomics, metabolomics, and proteomics. The production of therapeutic proteins and other drugs has been aided by the growing use of biotech solutions. The need for drug research and development has grown as the prevalence of chronic diseases has increased. Owing to the specific design of the application, it is being used more frequently in other industrial sectors. The increasing use of organic products in agriculture is also contributing to market growth.
The global Biotechnology market is segregated on the basis of Technology as Nanobiotechnology, Tissue Engineering and Regeneration, DNA Sequencing, Cell-based Assays, Fermentation, PCR Technology, Chromatography, and Others. Based on Application the global Biotechnology market is segmented in Health, Food & Agriculture, Natural Resources & Environment, Industrial Processing, Bioinformatics, and Others.
The global Biotechnology market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Biotechnology market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Gilead, AstraZeneca, Arkray, Inc, CELGENE CORPORATION, Bayer Corporation, Biogen, Abbott Laboratories, LifeScan, Inc, Amgen, Inc., Insulet Corporation, Novo Nordisk A/S, Merck & Co., Johnson & Johnson, Novartis AG, Sanofi Aventis, F. Hoffmann-La Roche Ltd., Pfizer, Inc., Lonza, and others are among the major players in the global Biotechnology market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Biotechnology Market has been segmented as below:
Biotechnology Market, By Technology
Biotechnology Market, By Application
Biotechnology Market, By Region
Biotechnology Market, By Company
The report covers:
Report Scope:
The global Biotechnology market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Biotechnology market share. Major industry players with significant revenue share include Gilead, AstraZeneca, Arkray, Inc, CELGENE CORPORATION, Bayer Corporation, Biogen, Abbott Laboratories, LifeScan, Inc, Amgen, Inc., Insulet Corporation, Novo Nordisk A/S, Merck& Co., Johnson & Johnson, Novartis AG, Sanofi Aventis, F. Hoffmann-La Roche Ltd., Pfizer, Inc., Lonza, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Biotechnology market, by Technology
5.1 Introduction
5.2 Nanobiotechnology
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Tissue Engineering and Regeneration
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 DNA Sequencing
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Cell-based Assays
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Fermentation
5.6.1 Market Overview
5.6.2 Market Size and Forecast
5.7 PCR Technology
5.7.1 Market Overview
5.7.2 Market Size and Forecast
5.8 Chromatography
5.8.1 Market Overview
5.8.2 Market Size and Forecast
5.9 Others
5.9.1 Market Overview
5.9.2 Market Size and Forecast
6. Biotechnology market, by Application
6.1 Introduction
6.2 Health
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Food & Agriculture
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Natural Resources & Environment
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Industrial Processing
6.5.1 Market Overview
6.5.2 Market Size and Forecast
6.6 Bioinformatics
6.6.1 Market Overview
6.6.2 Market Size and Forecast
6.7 Others
6.7.1 Market Overview
6.7.2 Market Size and Forecast
7. Biotechnology Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Biotechnology, By Technology
7.2.2 North America Biotechnology, By Application
7.3 Europe
7.3.1 Europe Biotechnology, By Technology
7.3.2 Europe Biotechnology, By Application
7.4 Asia-Pacific
7.4.1 Asia-Pacific Biotechnology, By Technology
7.4.2 Asia-Pacific Biotechnology, By Application
7.5 Rest of the World
7.5.1 Rest of the World Biotechnology, By Technology
7.5.2 Rest of the World Biotechnology, By Application
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 Gilead
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 AstraZeneca
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Arkray, Inc
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 CELGENE CORPORATION
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Bayer Corporation
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Biogen
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Abbott Laboratories
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 LifeScan, Inc
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 Amgen, Inc.
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
9.10 Insulet Corporation
9.10.1 Company Overview
9.10.2 Product/Service Landscape
9.10.3 Financial Overview
9.10.4 Recent Developments
9.11 Novo Nordisk A/S
9.11.1 Company Overview
9.11.2 Product/Service Landscape
9.11.3 Financial Overview
9.11.4 Recent Developments
9.12 Merck& Co.
9.12.1 Company Overview
9.12.2 Product/Service Landscape
9.12.3 Financial Overview
9.12.4 Recent Developments
9.13 Johnson & Johnson
9.13.1 Company Overview
9.13.2 Product/Service Landscape
9.13.3 Financial Overview
9.13.4 Recent Developments
9.14 Novartis AG
9.14.1 Company Overview
9.14.2 Product/Service Landscape
9.14.3 Financial Overview
9.14.4 Recent Developments
9.15 Sanofi Aventis
9.15.1 Company Overview
9.15.2 Product/Service Landscape
9.15.3 Financial Overview
9.15.4 Recent Developments
9.16 F. Hoffmann-La Roche Ltd.
9.16.1 Company Overview
9.16.2 Product/Service Landscape
9.16.3 Financial Overview
9.16.4 Recent Developments
9.17 Pfizer, Inc.
9.17.1 Company Overview
9.17.2 Product/Service Landscape
9.17.3 Financial Overview
9.17.4 Recent Developments
9.18 Lonza
9.18.1 Company Overview
9.18.2 Product/Service Landscape
9.18.3 Financial Overview
9.18.4 Recent Developments
The Biotechnology Market has been segmented as below:
Biotechnology Market, By Technology
Biotechnology Market, By Application
Biotechnology Market, By Region
SUBSCRIBE TO OUR NEWSLETTERS
